Stock Research for XOMA

XOMA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

XOMA Stock Chart & Research Data

The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


XOMA Due diligence Resources & Stock Charts

The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View XOMA Detailed Price Forecast - CNN Money CNN View XOMA Detailed Summary - Google Finance
Yahoo View XOMA Detailed Summary - Yahoo! Finance Zacks View XOMA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View XOMA Trends & Analysis - Trade-Ideas Barrons View XOMA Major Holders - Barrons
NASDAQ View XOMA Call Transcripts - NASDAQ Seeking View XOMA Breaking News & Analysis - Seeking Alpha
Spotlight View XOMA Annual Report - CompanySpotlight.com OTC Report View XOMA OTC Short Report - OTCShortReport.com
TradeKing View XOMA Fundamentals - TradeKing Charts View XOMA SEC Filings - Bar Chart
WSJ View Historical Prices for XOMA - The WSJ Morningstar View Performance/Total Return for XOMA - Morningstar
MarketWatch View the Analyst Estimates for XOMA - MarketWatch CNBC View the Earnings History for XOMA - CNBC
StockMarketWatch View the XOMA Earnings - StockMarketWatch MacroAxis View XOMA Buy or Sell Recommendations - MacroAxis
Bullish View the XOMA Bullish Patterns - American Bulls Short Pains View XOMA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View XOMA Stock Mentions - StockTwits PennyStocks View XOMA Stock Mentions - PennyStockTweets
Twitter View XOMA Stock Mentions - Twitter Invest Hub View XOMA Investment Forum News - Investor Hub
Yahoo View XOMA Stock Mentions - Yahoo! Message Board Seeking Alpha View XOMA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for XOMA - SECform4.com Insider Cow View Insider Transactions for XOMA - Insider Cow
CNBC View XOMA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for XOMA - OTC Markets
Yahoo View Insider Transactions for XOMA - Yahoo! Finance NASDAQ View Institutional Holdings for XOMA - NASDAQ


Stock Charts

FinViz View XOMA Stock Insight & Charts - FinViz.com StockCharts View XOMA Investment Charts - StockCharts.com
BarChart View XOMA Stock Overview & Charts - BarChart Trading View View XOMA User Generated Charts - Trading View




Latest Financial News for XOMA


XOMA Corporation Announces Closing of Tender Offer
Posted on Wednesday April 03, 2024

Kinnate Stockholders to Receive $2.5879 Per Share in Cash Plus Contingent Value RightEMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Kinnate Biopharma Inc. (NASDAQ: KN


XOMA Declares Quarterly Preferred Stock Dividends
Posted on Thursday March 21, 2024

EMERYVILLE, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share. Holders of depositary shares, each representing 1/1000 of a share of XOMA’s 8.375% Series


XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Posted on Tuesday March 19, 2024

Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolioEMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation (“XOMA” or the “Company”; Nasdaq: XOMA) entered into a merger agreement to acquire Kinnate Biopharma Inc. (“Kinnate”; Nasdaq: KNTE) for (i) a base cash price per share of Kinnate common stock of $2.3352 per share


XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
Posted on Friday March 08, 2024

Key Financial Highlights and Upcoming Events Set to Influence Future Growth


Stock Market & Investing Books

Enter a stock symbol to view the stock details.